{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T14:48:10Z","timestamp":1770475690254,"version":"3.49.0"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3679,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1365-2133.2005.06812.x","type":"journal-article","created":{"date-parts":[[2005,8,20]],"date-time":"2005-08-20T02:12:18Z","timestamp":1124503938000},"page":"689-691","source":"Crossref","is-referenced-by-count":29,"title":["Severe recalcitrant pyoderma gangrenosum treated with infliximab"],"prefix":"10.1093","volume":"153","author":[{"given":"M.R.","family":"Kaur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.M.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,8,5]]},"reference":[{"key":"10.1111\/j.1365-2133.2005.06812.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1046\/j.1365-2133.2001.04036.x","article-title":"Severe recalcitrant pyoderma gangrenosum responding to a combination of mycophenolate mofetil with ciclosporin and complicated by a mononeuritis","volume":"144","author":"Gilmour","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2005.06812.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2230.2004.01470.x","article-title":"Infliximab as a treatment for recalcitrant pyoderma gangrenosum","volume":"29","author":"Singh","year":"2004","journal-title":"Clin Exper Dermatol"},{"key":"10.1111\/j.1365-2133.2005.06812.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1111\/j.1572-0241.2003.07581.x","article-title":"Infliximab for the treatment of pyoderma gangrenosum associated with inflammatory bowel disease","volume":"98","author":"Regueiro","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2133.2005.06812.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1159\/000065860","article-title":"Corticosteroid-resistant pyoderma gangrenosum associated with crohns disease: rapid cure with infliximab","volume":"205","author":"Grange","year":"2002","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2005.06812.x-BIB5|cit5","first-page":"258","article-title":"Anti-tumour necrosis factor alpha monoclonal antibody (infliximab) for the treatment of pyoderma gangrenosum associated with crohns disease","volume":"13","author":"Zaccagna","year":"2003","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1365-2133.2005.06812.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1080\/gas.37.7.863.865","article-title":"Favourable response to infliximab treatment in a patient with active Crohn's disease and pyoderma gangrenosum","volume":"37","author":"Triantafillidis","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"10.1111\/j.1365-2133.2005.06812.x-BIB7|cit7","first-page":"930","article-title":"Improvement of pyoderma gangrenosum and psoriasis associated with Crohn's disease and anti-tumour necrosis factor alpha monoclonal antibody","volume":"137","author":"Tan","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2005.06812.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00005792-200001000-00004","article-title":"Pyoderma gangrenosum: a comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions","volume":"79","author":"Bennett","year":"2000","journal-title":"Medicine"},{"key":"10.1111\/j.1365-2133.2005.06812.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/09546630410017275","article-title":"A comprehensive review and evaluation of the side effects of the tumour necrosis factor alpha blockers etanercept, infliximab and adalimumab","volume":"15","author":"Scheinfeld","year":"2004","journal-title":"J Dermatol Treat"},{"key":"10.1111\/j.1365-2133.2005.06812.x-BIB10|cit10","unstructured":"http:\/\/www.FdaGov\/Searchoncder\/Foi\/Label2002\/Inflcen022702LB.pdf"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2005.06812.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2005.06812.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:14:17Z","timestamp":1676384057000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/153\/3\/689\/6637105"}},"subtitle":["Correspondence"],"short-title":[],"issued":{"date-parts":[[2005,8,5]]},"references-count":10,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2005.06812.x","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8,5]]}}}